Taken together, these data support the targeting of IL-1α/IL-1R1 and dendritic cell function as a strategy for managing smoke-induced inflammation and processes underlying the pathogenesis of COPD. This evidence concerns the gene IL1A and chronic obstructive pulmonary disease.